Kinetiq shows strong early-maturity signals with about USD one billion kHYPE TVL and an more than eighty percent share of the Hyperliquid LST market. Until HIP three Markets, Launch, KIP one buybacks, and sKNTQ revenue are proven over time, Hyperliquid concentration and external operating dependence remain risks.
Investment View
Kinetiq should be evaluated through validator allocation, sKNTQ buyback execution, HIP three Launch revenue, and external vault risk, not only kHYPE TVL.
Source PDF
The PDF report is available alongside the slide viewer.
Report Type
Project Maturity Analysis
Version
v1
Analysis Date
July 17, 2026
Language
en
Disclaimer: This report is generated through AI-powered analysis and market data. This is not investment advice. All investment decisions should be made at your own risk.